Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Influence of Lifestyle Modifications on Age-Related Free Radical Injury to Brain.

Peskind ER, Li G, Shofer JB, Millard SP, Leverenz JB, Yu CE, Raskind MA, Quinn JF, Galasko DR, Montine TJ.

JAMA Neurol. 2014 Jul 21. doi: 10.1001/jamaneurol.2014.1428. [Epub ahead of print]

PMID:
25048271
[PubMed - as supplied by publisher]
2.

The neurobiological basis of cognitive impairment in Parkinson's disease.

Halliday GM, Leverenz JB, Schneider JS, Adler CH.

Mov Disord. 2014 Apr 15;29(5):634-50. doi: 10.1002/mds.25857.

PMID:
24757112
[PubMed - in process]
3.

Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span.

Li G, Millard SP, Peskind ER, Zhang J, Yu CE, Leverenz JB, Mayer C, Shofer JS, Raskind MA, Quinn JF, Galasko DR, Montine TJ.

JAMA Neurol. 2014 Jun;71(6):742-51. doi: 10.1001/jamaneurol.2014.445.

PMID:
24756381
[PubMed - in process]
4.

Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL.

Mov Disord. 2014 May;29(6):756-64. doi: 10.1002/mds.25875. Epub 2014 Apr 7.

PMID:
24710804
[PubMed - in process]
5.

Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's disease.

Cornejo-Olivas MR, Yu CE, Mazzetti P, Mata IF, Meza M, Lindo-Samanamud S, Leverenz JB, Bird TD.

Neurosci Lett. 2014 Mar 20;563:140-3. doi: 10.1016/j.neulet.2014.01.016. Epub 2014 Feb 2.

PMID:
24495933
[PubMed - in process]
6.

Memory, mood, and vitamin d in persons with Parkinson's disease.

Peterson AL, Murchison C, Zabetian C, Leverenz JB, Watson GS, Montine T, Carney N, Bowman GL, Edwards K, Quinn JF.

J Parkinsons Dis. 2013;3(4):547-55. doi: 10.3233/JPD-130206.

PMID:
24081441
[PubMed - in process]
Free PMC Article
7.

Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control.

Stewart T, Sui YT, Gonzalez-Cuyar LF, Wong DT, Akin DM, Tumas V, Aasly J, Ashmore E, Aro P, Ginghina C, Korff A, Zabetian CP, Leverenz JB, Shi M, Zhang J.

Neurobiol Aging. 2014 Feb;35(2):418-20. doi: 10.1016/j.neurobiolaging.2013.08.008. Epub 2013 Sep 13.

PMID:
24041968
[PubMed - in process]
8.

Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects.

Millard SP, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang D, Yu CE, Peskind ER, Bekris LM.

Neurobiol Aging. 2014 Feb;35(2):357-64. doi: 10.1016/j.neurobiolaging.2013.07.027. Epub 2013 Sep 4.

PMID:
24011543
[PubMed - in process]
9.

Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics.

Cholerton BA, Zabetian CP, Quinn JF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Edwards KL, Montine TJ, Leverenz JB.

J Parkinsons Dis. 2013;3(2):205-14. doi: 10.3233/JPD-130189.

PMID:
23938350
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma.

Bekris LM, Lutz F, Montine TJ, Yu CE, Tsuang D, Peskind ER, Leverenz JB.

Biomarkers. 2013 Aug;18(5):455-66. doi: 10.3109/1354750X.2013.814073. Epub 2013 Jul 3.

PMID:
23822153
[PubMed - indexed for MEDLINE]
11.

Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial.

Hanson AJ, Bayer-Carter JL, Green PS, Montine TJ, Wilkinson CW, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Tsai E, Postupna N, Zhang J, Lampe J, Craft S.

JAMA Neurol. 2013 Aug;70(8):972-80. doi: 10.1001/jamaneurol.2013.396.

PMID:
23779114
[PubMed - indexed for MEDLINE]
12.

Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

Chahine LM, Qiang J, Ashbridge E, Minger J, Yearout D, Horn S, Colcher A, Hurtig HI, Lee VM, Van Deerlin VM, Leverenz JB, Siderowf AD, Trojanowski JQ, Zabetian CP, Chen-Plotkin A.

JAMA Neurol. 2013 Jul;70(7):852-8. doi: 10.1001/jamaneurol.2013.1274.

PMID:
23699752
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).

Korvatska O, Strand NS, Berndt JD, Strovas T, Chen DH, Leverenz JB, Kiianitsa K, Mata IF, Karakoc E, Greenup JL, Bonkowski E, Chuang J, Moon RT, Eichler EE, Nickerson DA, Zabetian CP, Kraemer BC, Bird TD, Raskind WH.

Hum Mol Genet. 2013 Aug 15;22(16):3259-68. doi: 10.1093/hmg/ddt180. Epub 2013 Apr 16.

PMID:
23595882
[PubMed - indexed for MEDLINE]
14.

CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration.

Liachko NF, McMillan PJ, Guthrie CR, Bird TD, Leverenz JB, Kraemer BC.

Ann Neurol. 2013 Jul;74(1):39-52. doi: 10.1002/ana.23870. Epub 2013 Jul 8.

PMID:
23424178
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

APOE ε4 increases risk for dementia in pure synucleinopathies.

Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP.

JAMA Neurol. 2013 Feb;70(2):223-8. doi: 10.1001/jamaneurol.2013.600.

PMID:
23407718
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease.

Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J.

Sci Rep. 2012;2:954. doi: 10.1038/srep00954. Epub 2012 Dec 11.

PMID:
23233873
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

Watson GS, Cholerton BA, Gross RG, Weintraub D, Zabetian CP, Trojanowski JQ, Montine TJ, Siderowf A, Leverenz JB.

Alzheimers Dement. 2013 Sep;9(5):609-14. doi: 10.1016/j.jalz.2012.07.006. Epub 2012 Nov 16.

PMID:
23164549
[PubMed - indexed for MEDLINE]
18.

Neuropathologic substrates of Parkinson disease dementia.

Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ.

Ann Neurol. 2012 Oct;72(4):587-98. doi: 10.1002/ana.23659. Epub 2012 Oct 4.

PMID:
23037886
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.

Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Trojanowski JQ, Schellenberg GD, Yearout D, Huston H, Fritts-Penniman A, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP.

Neurology. 2012 Nov 6;79(19):1944-50. doi: 10.1212/WNL.0b013e3182735e9a. Epub 2012 Oct 3.

PMID:
23035075
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease.

Bekris LM, Millard S, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Yu CE, Peskind ER.

Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):874-83. doi: 10.1002/ajmg.b.32094. Epub 2012 Aug 27.

PMID:
22927204
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk